REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...

The past decade has delivered landmark advances in human and medical genomics that shape how we understand disease mechanisms ...

The Global Consumer Genomics Market is primed for growth due to decreasing sequencing costs and rising health awareness, ...

Spanish cancer biomarker medtech Reveal Genomics has boosted the roles of three of its founding members. | Spanish cancer biomarker medtech Reveal Genomics has boosted the roles of three of its ...

Why 10x Genomics is on investors’ radar today 10x Genomics (TXG) has drawn fresh attention after recent trading, with the ...

Artificial intelligence has gotten a bad reputation lately, and often for good reason. But a team of scientists at Google’s ...

Cathie Wood's ARK sold $2.78M Twist Bioscience, bought Tempus AI & WeRide Jan 26. Full breakdown of ARK Invest's latest AI ...

As cancer care increasingly shifts toward data-driven decision-making, 4baseCare is positioning itself at the intersection of genomics, AI, and clinical practice.The Bengaluru-based precision oncology ...

Someday, the information in our genome could transform healthcare as we know it, but one major hurdle we have to get over is ...

Baylor College of Medicine researchers are part of a collaborative research group with AstraZeneca and Memorial Sloan ...

Genomics and life sciences pioneer J. Craig Venter, Ph.D., is back with a new J. | Genomics and life sciences pioneer J.

DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene expression ...